Picard Medical is trading 5.28% lower at $12.01; no clear company-specific announcement explains the October 15 pre-market move.

  • Shares had already fallen 17.29% on October 14 after a sharp run-up. A securities-lawsuit development was reported October 13, but that timing does not establish it caused the decline.
  • Hotter-than-expected U.S. inflation data pressured broader markets. Reuters reported declines in U.S. indexes and Asian markets amid higher-rate concerns, with no direct evidence linking those moves to Picard Medical.